Clinical trial NCT06110624: The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
Official title: The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Palliative Medicine
Lead sponsor: University Medical Center Groningen
Sponsor class: OTHER
First posted: 2023-10-31
Enrollment: 20
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.

Brief summary: A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Detailed description: A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Eligibility criteria: Inclusion Criteria:

Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:

* General practice
* Nursing home
* Hospital:

  * Clinical geriatrics
  * Medical oncology
  * Radiation oncology
  * Pulmonology
  * Cardiology

Exclusion Criteria:

HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.

GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Primary outcomes:
measure: Questions evaluating Intention to Use (IU)
timeFrame: after 5 times use of the MuSt-PC tool within 3 months
Secondary outcomes:
measure: Questions evaluating other modified TAM domains
timeFrame: after 5 times use of the MuSt-PC tool within 3 months
measure: Perceived benefits and disadvantages of using MuSt-PC
timeFrame: after 5 times use within 3 months
measure: Suggestions to improve the MuSt-PC CDSS
timeFrame: after 5 times of the MuSt-PC tool within 3 months
measure: An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
timeFrame: after 5 times use within 3 months
measure: Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
timeFrame: after 5 times use within 3 months
measure: Mean scores of HCPs adherence to CDSS recommendations
timeFrame: after 5 times use of the MuSt-PC tool within 3 months
Other outcomes:
measure: A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use
timeFrame: after 5 times use of the MuSt-PC tool within 3 months
Locations:
city: Groningen
country: Netherlands
facility: University Medical Center Groningen
city: Leiden
country: Netherlands
facility: LUMC
Study officials:
affiliation: University Medical Center Groningen
name: An KL Reyners, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References: